150 related articles for article (PubMed ID: 9569080)
21. Microemulsion formulation of cyclosporin (Sandimmun Neoral) vs Sandimmun: comparative safety, tolerability and efficacy in severe active rheumatoid arthritis. On behalf of the OLR 302 Study Group.
Yocum DE; Allard S; Cohen SB; Emery P; Flipo RM; Goobar J; Jayawardena S; Job-Deslandre C; Jubb RW; Krüger K; Lopes Vaz A; Manger B; Mur E; Nygaard H; Weiner SM; Rainer F; Sack MR; Schiff MH; Schnitzer TJ; Trigg LB; Whatmough I; Schmidt AG
Rheumatology (Oxford); 2000 Feb; 39(2):156-64. PubMed ID: 10725065
[TBL] [Abstract][Full Text] [Related]
22. The beneficial effects of treatment with all-trans-retinoic acid plus corticosteroid on autoimmune nephritis in NZB/WF mice.
Nozaki Y; Yamagata T; Yoo BS; Sugiyama M; Ikoma S; Kinoshita K; Funauchi M; Kanamaru A
Clin Exp Immunol; 2005 Jan; 139(1):74-83. PubMed ID: 15606616
[TBL] [Abstract][Full Text] [Related]
23. Successful Discontinuation of Glucocorticoid Treatment after Administration of a Calcineurin Inhibitor for Nephrotic Syndrome in a Patient with Lupus Nephritis.
Sawamura M; Sawa N; Ikuma D; Oba Y; Yamanouchi M; Sekine A; Mizuno H; Hasegawa E; Suwabe T; Hoshino J; Kono K; Kinowaki K; Ohashi K; Ubara Y
Intern Med; 2023 Apr; 62(7):1037-1041. PubMed ID: 36070938
[TBL] [Abstract][Full Text] [Related]
24. Mycophenolate mofetil for remission induction in severe lupus nephritis.
Cross J; Dwomoa A; Andrews P; Burns A; Gordon C; Main J; Mathieson P; O'Donoghue D; Jayne D;
Nephron Clin Pract; 2005; 100(3):c92-100. PubMed ID: 15824513
[TBL] [Abstract][Full Text] [Related]
25. Study of the efficacy of mizoribine in lupus nephritis in Chinese patients.
Zhang M; Xing CY; Liu J
Rheumatol Int; 2013 Nov; 33(11):2737-42. PubMed ID: 23797779
[TBL] [Abstract][Full Text] [Related]
26. Implication of the peak serum level of mizoribine for control of the serum anti-dsDNA antibody titer in patients with lupus nephritis.
Tanaka H; Tsugawa K; Nakahata T; Kudo M; Suzuki K; Ito E
Clin Nephrol; 2005 Jun; 63(6):417-22. PubMed ID: 15960142
[TBL] [Abstract][Full Text] [Related]
27. Management of young patients with lupus nephritis using tacrolimus administered as a single daily dose.
Tanaka H; Oki E; Tsuruga K; Yashiro T; Hanada I; Ito E
Clin Nephrol; 2009 Dec; 72(6):430-6. PubMed ID: 19954719
[TBL] [Abstract][Full Text] [Related]
28. Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
Szeto CC; Kwan BC; Lai FM; Tam LS; Li EK; Chow KM; Gang W; Li PK
Rheumatology (Oxford); 2008 Nov; 47(11):1678-81. PubMed ID: 18753192
[TBL] [Abstract][Full Text] [Related]
29. Remission from lupus nephritis resistant to cyclophosphamide after additional treatment with cyclosporin A.
Ferrario L; Bellone M; Bozzolo E; Baldissera E; Sabbadini MG
Rheumatology (Oxford); 2000 Feb; 39(2):218-220. PubMed ID: 10725082
[No Abstract] [Full Text] [Related]
30. [A clinical study on low dose cyclosporin A in the treatment of lupus nephritis].
Yin PD; Yang XY
Zhonghua Nei Ke Za Zhi; 1994 Oct; 33(10):684-6. PubMed ID: 7712918
[TBL] [Abstract][Full Text] [Related]
31. Effects of cyclosporine A on serum and urinary soluble interleukin-2 receptor in patients with lupus nephritis.
Tang Z; Zhang J; Zhang S; Li L
Chin Med J (Engl); 1997 Sep; 110(9):686-9. PubMed ID: 9642325
[TBL] [Abstract][Full Text] [Related]
32. Captopril effect on prostaglandin E2, thromboxane B2 and proteinuria in lupus nephritis patients.
Daza L; Kornhauser C; Zamora L; Flores J
Prostaglandins Other Lipid Mediat; 2005 Dec; 78(1-4):194-201. PubMed ID: 16303616
[TBL] [Abstract][Full Text] [Related]
33. A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis.
Boumpas DT; Furie R; Manzi S; Illei GG; Wallace DJ; Balow JE; Vaishnaw A;
Arthritis Rheum; 2003 Mar; 48(3):719-27. PubMed ID: 12632425
[TBL] [Abstract][Full Text] [Related]
34. Randomized trial of cyclosporine microemulsion (neoral) versus conventional cyclosporine in liver transplantation: MILTON study. Multicentre International Study in Liver Transplantation of Neoral.
Otto MG; Mayer AD; Clavien PA; Cavallari A; Gunawardena KA; Mueller EA
Transplantation; 1998 Dec; 66(12):1632-40. PubMed ID: 9884251
[TBL] [Abstract][Full Text] [Related]
35. Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy.
Austin HA; Illei GG; Braun MJ; Balow JE
J Am Soc Nephrol; 2009 Apr; 20(4):901-11. PubMed ID: 19297556
[TBL] [Abstract][Full Text] [Related]
36. [Complete remission of minimal change nephrotic syndrome with type 2 diabetes mellitus treated by microemulsion formulation of cyclosporin and fluvastatin].
Makibayashi K; Fukatsu A; Kita T
Nihon Jinzo Gakkai Shi; 2002 Mar; 44(2):109-13. PubMed ID: 11974950
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of serum C3 and CH50 levels as markers of disease-activity and indicators of efficacy of treatment of lupus nephritis in childhood].
Ibe M; Kuriyama T; Mori M; Mitsuda T; Aihara Y; Yokota S
Ryumachi; 1994 Aug; 34(4):715-24. PubMed ID: 7974022
[TBL] [Abstract][Full Text] [Related]
38. Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis.
Tanaka H; Tsugawa K; Suzuki K; Nakahata T; Ito E
Pediatr Nephrol; 2006 Jul; 21(7):962-6. PubMed ID: 16773408
[TBL] [Abstract][Full Text] [Related]
39. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
[TBL] [Abstract][Full Text] [Related]
40. Intermittent intravenous pulse cyclophosphamide treatment in systemic lupus erythematosus.
Malaviya AN; Singh RR; Sindhwani R; Singh YN; Ahujà RK; Bhuyan UN; Khare SD; Kumar A; Malaviya R; Negi PC
Indian J Med Res; 1992 Apr; 96():101-8. PubMed ID: 1428048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
